BOTOX for Jaw Pain

Botox® Treatment for TMJD (Temporo-Mandibular Joint Disorder)

Call Dr. Lori Ann Safar at 858-481-8688 for FREE consultation.

BOTOX© injections are an extremely effective and easy remedy for those of us who suffer from TMJD as well as excessive teeth grinding, headaches and lock jaw. Dr. Lori Ann Safar is proud to offer this alternative therapy at Celebrity Smile Spa because of its increasing success with patients worldwide.

The Temporo-Mandibular Joint is located on both sides of the head at the point where the jawbone meets the skull. This joint is used during talking, chewing, swallowing, and many other everyday activities. If this joint becomes displaced or is overworked through excessive teeth grinding, severe tension headaches and sharp pain may result. When BOTOX© is injected into the facial muscles afflicted with soreness and discomfort it relieves TMJD and jaw tension for many patients. The injections often eliminate headaches resulting from teeth grinding, and in cases of severe stress, BOTOX© can even minimize lock jaw.

Many TMJD sufferers are unaware of the attrition occurring in their temporo-mandibular joint. This is due to constant, unconscious, movement of the jaw. BOTOX© is a successful treatment for this problem because the injections allow the muscles surrounding the joint to relax and inhibits the problematic grinding. In addition, this treatment can help safeguard dental health, since excessive grinding can result in worn teeth, cracked teeth, bone loss and damaged gums that may require costly treatment.

BOTOX© is a simple, non-surgical procedure. The injections are administered here, at Celebrity Smile Spa, by Dr. Safar, herself. No hospitalization required. Side effects are minimal and may include; mild and temporary pain, bruising, numbness or redness at the injection site, headaches, temporary nausea or excessive muscle weakness.

While BOTOX© treatment for TMJD appears to be quite safe, certain medications, intoxicants, and other substances can minimize or negatively impact the effectiveness of BOTOX© injections. For this reason, patients should honestly disclose any medication or substance use to Dr. Safar prior to treatment. Although complications are rare, all possible risks should be discussed.

Currently, the use of BOTOX© therapy for TMJD is not covered by medical insurance plans. However, because TMJD are largely a dental issue, it is conceivable that insurance companies will ultimately cover BOTOX© injections as a means of preventing damage to the teeth and gums caused by excessive grinding.

If you or someone you know suffers from TMJD or experiences any of the painful symptoms associated with this problem, Dr. Safar strongly encourages you to come in for a free consultation to discuss the possibility of BOTOX© therapy. Kiss your pain goodbye with this simple and effective treatment!

The dose of BOTOX® and BOTOX® Cosmetic is not the same as, or comparable to, another botulinum toxin product.
Serious and/or immediate allergic reactions have been reported. These reactions include itching, rash, red itchy welts, wheezing, asthma symptoms, or dizziness or feeling faint. Tell your doctor or get medical help right away if you experience any such symptoms; further injection of BOTOX® or BOTOX® Cosmetic should be discontinued.


Distant Spread of Toxin Effect
Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, blurred vision, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening, and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have underlying conditions that would predispose them to these symptoms. In unapproved uses, including spasticity in children and adults, and in approved indications, cases of spread of effect have occurred at doses comparable to those used to treat cervical dystonia and at lower doses.

BOTOX® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation.

The recommended dosage and frequency of administration for BOTOX® Cosmetic should not be exceeded. Risks resulting from administration at higher dosages are not known.

Lack of Interchangeability Between Botulinum Toxin Products
The potency Units of BOTOX® Cosmetic are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, Units of biological activity of BOTOX® Cosmetic cannot be compared to or converted into Units of any other botulinum toxin products assessed with any other specific assay method.

Spread of Toxin Effect
Please refer to Boxed Warning for Distant Spread of Toxin Effect.

No definitive, serious adverse event reports of distant spread of toxin effect associated with dermatologic use of BOTOX® Cosmetic at the labeled dose of 20 Units (for glabellar lines) have been reported.

Hypersensitivity Reactions
Serious and/or immediate hypersensitivity reactions have been reported. These reactions include anaphylaxis, urticaria, soft-tissue edema, and dyspnea. If such reactions occur, further injection of BOTOX® Cosmetic should be discontinued and appropriate medical therapy immediately instituted. One fatal case of anaphylaxis has been reported in which lidocaine was used as the diluent and, consequently, the causal agent cannot be reliably determined.

Pre-existing Neuromuscular Disorders
Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junctional disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored particularly closely when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including severe dysphagia and respiratory compromise from typical doses of BOTOX® Cosmetic.

Human Albumin
This product contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases. A theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD) also is considered extremely remote. No cases of transmission of viral diseases or CJD have ever been identified for albumin.

Caution should be used when BOTOX® Cosmetic treatment is used in patients who have an inflammatory skin problem at the injection site, marked facial asymmetry, ptosis, excessive dermatochalasis, deep dermal scarring, thick sebaceous skin, or the inability to substantially lessen glabellar lines by physically spreading them apart.

Information for Patients
Patients should be counseled that if loss of strength, muscle weakness, or impaired vision occur, they should avoid driving a car or engaging in other potentially hazardous activities.

Drug Interactions
Co-administration of BOTOX® Cosmetic and aminoglycosides or other agents interfering with neuromuscular transmission (eg, curare-like nondepolarizing blockers, lincosamides, polymyxins, quinidine, magnesium sulfate, anticholinesterases, succinylcholine chloride) should only be performed with caution as the effect of the toxin may be potentiated.

The effect of administering different botulinum neurotoxin serotypes at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin.

Administration of BOTOX® Cosmetic is not recommended during pregnancy. There are no adequate and well-controlled studies of BOTOX® Cosmetic in pregnant women.

Nursing Mothers
It is not known whether BOTOX® Cosmetic is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when BOTOX® Cosmetic is administered to a nursing woman.

The most serious adverse events reported after treatment with botulinum toxin include spontaneous reports of death, sometimes associated with anaphylaxis, dysphagia, pneumonia, and/or other significant debility.

There have also been reports of adverse events involving the cardiovascular system, including arrhythmia and myocardial infarction, some with fatal outcomes. Some of these patients had risk factors including pre-existing cardiovascular disease.

Contact Us